Literature DB >> 16709607

Endogenous interleukin-10 protects against hepatic steatosis but does not improve insulin sensitivity during high-fat feeding in mice.

Marion A M den Boer1, Peter J Voshol, Janny P Schröder-van der Elst, Elena Korsheninnikova, D Margriet Ouwens, Folkert Kuipers, Louis M Havekes, Johannes A Romijn.   

Abstract

Several studies have demonstrated an association in humans between plasma levels or production capacity of the antiinflammatory cytokine IL-10 and insulin sensitivity. The aim of our study was to investigate the protective role of endogenous IL-10 availability in the development of diet-induced insulin resistance. We compared parameters of glucose and lipid metabolism between IL-10(-/-) mice and wild-type (wt) mice fed a high-fat diet for 6 wk. This diet has previously been shown to induce steatosis and insulin resistance. After 6 wk on the high-fat diet, no differences in body weight, basal metabolism (measured by indirect calorimetry), or plasma levels of glucose, triglycerides, or cholesterol were observed between IL-10(-/-) and wt mice. Nonetheless, in IL-10(-/-) mice, plasma free fatty acid levels were 75% increased compared with wt mice after overnight fasting (P < 0.05). In addition, hepatic triglyceride content was 54% increased in IL-10(-/-) mice (P < 0.05). During a hyperinsulinemic euglycemic clamp, no differences were observed in whole-body or hepatic insulin sensitivity between both groups. We conclude that basal IL-10 production protects against hepatic steatosis but does not improve hepatic or whole-body insulin sensitivity, during high-fat feeding.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16709607     DOI: 10.1210/en.2006-0417

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  28 in total

1.  Hepatic gene networks in morbidly obese patients with nonalcoholic fatty liver disease.

Authors:  Samer Gawrieh; Tesfaye M Baye; Melanie Carless; James Wallace; Richard Komorowski; David E Kleiner; Deborah Andris; Bassem Makladi; Regina Cole; Michael Charlton; Joanne Curran; Thomas D Dyer; Jac Charlesworth; Russell Wilke; John Blangero; Ahmed H Kissebah; Michael Olivier
Journal:  Obes Surg       Date:  2010-12       Impact factor: 4.129

Review 2.  What does irritable bowel syndrome share with non-alcoholic fatty liver disease?

Authors:  Antonella Scalera; Matteo Nicola Dario Di Minno; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 3.  Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication.

Authors:  Jan-Bernd Funcke; Philipp E Scherer
Journal:  J Lipid Res       Date:  2019-06-17       Impact factor: 5.922

Review 4.  Immune Cells Gate White Adipose Tissue Expansion.

Authors:  Aaron R Cox; Natasha Chernis; Peter M Masschelin; Sean M Hartig
Journal:  Endocrinology       Date:  2019-07-01       Impact factor: 4.736

5.  Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice.

Authors:  Andrew M Miller; Hua Wang; Adeline Bertola; Ogyi Park; Norio Horiguchi; Sung Hwan Ki; Shi Yin; Fouad Lafdil; Bin Gao
Journal:  Hepatology       Date:  2011-09-02       Impact factor: 17.425

Review 6.  Role of cytokines and chemokines in non-alcoholic fatty liver disease.

Authors:  Vincent Braunersreuther; Giorgio Luciano Viviani; François Mach; Fabrizio Montecucco
Journal:  World J Gastroenterol       Date:  2012-02-28       Impact factor: 5.742

Review 7.  Why do anti-inflammatory therapies fail to improve insulin sensitivity?

Authors:  Zhan-guo Gao; Jian-ping Ye
Journal:  Acta Pharmacol Sin       Date:  2011-10-31       Impact factor: 6.150

Review 8.  Genetics of non-alcoholic fatty liver disease: From susceptibility and nutrient interactions to management.

Authors:  Vishnubhotla Venkata Ravi Kanth; Mitnala Sasikala; Mithun Sharma; Padaki Nagaraja Rao; Duvvuru Nageshwar Reddy
Journal:  World J Hepatol       Date:  2016-07-18

9.  Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling.

Authors:  Alicia H Clementi; Allison M Gaudy; Nico van Rooijen; Robert H Pierce; Robert A Mooney
Journal:  Biochim Biophys Acta       Date:  2009-08-20

10.  Hydrodynamic delivery of mIL10 gene protects mice from high-fat diet-induced obesity and glucose intolerance.

Authors:  Mingming Gao; Chunbo Zhang; Yongjie Ma; Le Bu; Linna Yan; Dexi Liu
Journal:  Mol Ther       Date:  2013-06-18       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.